23 May 2013
Keywords: promising, ph, ii, results, nicox, hct, european
Article | 21 June 2004
At the European League Against Rheumatism's annual congress, held in Berlin, Germany, positive Phase II data were presented for NicOx' ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.